352 related articles for article (PubMed ID: 34758859)
1. m
Zhang Z; Zhang C; Yang Z; Zhang G; Wu P; Luo Y; Zeng Q; Wang L; Xue Q; Zhang Y; Sun N; He J
J Hematol Oncol; 2021 Nov; 14(1):190. PubMed ID: 34758859
[TBL] [Abstract][Full Text] [Related]
2. m
Zhang Z; Zhang C; Luo Y; Wu P; Zhang G; Zeng Q; Wang L; Yang Z; Xue L; Zheng B; Zeng H; Tan F; Xue Q; Gao S; Sun N; He J
BMC Med; 2021 Nov; 19(1):284. PubMed ID: 34802443
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analyses of N
Luo Y; Zhang Z; Zheng B; Wu P; Zhang G; Wang L; Zeng Q; Yang Z; Xue L; Zeng H; Tan F; Xue Q; Gao S; Sun N; He J
Cancer Sci; 2022 Dec; 113(12):4289-4299. PubMed ID: 36047973
[TBL] [Abstract][Full Text] [Related]
4. An immune checkpoint-based signature predicts prognosis and chemotherapy response for patients with small cell lung cancer.
Wang L; Wu P; Shen Z; Yu Q; Zhang Y; Ye F; Chen K; Zhao J
Int Immunopharmacol; 2023 Apr; 117():109827. PubMed ID: 36989973
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer.
Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053
[TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer.
Zhang Z; Wu P; Zhang C; Luo Y; Zhang G; Zeng Q; Wang L; Yang Z; Sun N; He J
Front Immunol; 2021; 12():745769. PubMed ID: 34867972
[TBL] [Abstract][Full Text] [Related]
7. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.
Sun Y; Shen W; Hu S; Lyu Q; Wang Q; Wei T; Zhu W; Zhang J
J Exp Clin Cancer Res; 2023 Mar; 42(1):65. PubMed ID: 36932427
[TBL] [Abstract][Full Text] [Related]
8. CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter.
Qiu Z; Zhu W; Meng H; Tong L; Li X; Luo P; Yi L; Zhang X; Guo L; Wei T; Zhang J
Theranostics; 2019; 9(16):4717-4729. PubMed ID: 31367252
[No Abstract] [Full Text] [Related]
9. MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer.
Ranade AR; Cherba D; Sridhar S; Richardson P; Webb C; Paripati A; Bowles B; Weiss GJ
J Thorac Oncol; 2010 Aug; 5(8):1273-8. PubMed ID: 20548249
[TBL] [Abstract][Full Text] [Related]
10. Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer.
Wu P; Zhang Z; Yang Z; Zhang C; Luo Y; Zhang G; Wang L; Xue Q; Sun N; He J
Cancer Immunol Immunother; 2023 Mar; 72(3):617-631. PubMed ID: 36002754
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer.
Yu J; Wang S; Zhao W; Duan J; Wang Z; Chen H; Tian Y; Wang D; Zhao J; An T; Bai H; Wu M; Wang J
Clin Cancer Res; 2018 May; 24(9):2148-2158. PubMed ID: 29437792
[No Abstract] [Full Text] [Related]
12. Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.
Wang Q; Zeng F; Sun Y; Qiu Q; Zhang J; Huang W; Huang J; Huang X; Guo L
Clin Cancer Res; 2018 Feb; 24(4):950-962. PubMed ID: 29208667
[No Abstract] [Full Text] [Related]
13. Chemotherapy Resistance Molecular Mechanism in Small Cell Lung Cancer.
Zhou J; Li Z; Li J; Gao B; Song W
Curr Mol Med; 2019; 19(3):157-163. PubMed ID: 30813876
[TBL] [Abstract][Full Text] [Related]
14. Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression.
Lochmann TL; Floros KV; Naseri M; Powell KM; Cook W; March RJ; Stein GT; Greninger P; Maves YK; Saunders LR; Dylla SJ; Costa C; Boikos SA; Leverson JD; Souers AJ; Krystal GW; Harada H; Benes CH; Faber AC
Clin Cancer Res; 2018 Jan; 24(2):360-369. PubMed ID: 29118061
[No Abstract] [Full Text] [Related]
15. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
Byers LA; Wang J; Nilsson MB; Fujimoto J; Saintigny P; Yordy J; Giri U; Peyton M; Fan YH; Diao L; Masrorpour F; Shen L; Liu W; Duchemann B; Tumula P; Bhardwaj V; Welsh J; Weber S; Glisson BS; Kalhor N; Wistuba II; Girard L; Lippman SM; Mills GB; Coombes KR; Weinstein JN; Minna JD; Heymach JV
Cancer Discov; 2012 Sep; 2(9):798-811. PubMed ID: 22961666
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-Regulated microRNA-125-HER2 Pathway as a Novel Therapeutic Target for Trastuzumab-Mediated Cellular Cytotoxicity in Small Cell Lung Cancer.
Yagishita S; Fujita Y; Kitazono S; Ko R; Nakadate Y; Sawada T; Kitamura Y; Shimoyama T; Maeda Y; Takahashi F; Takahashi K; Tamura T; Koizumi F
Mol Cancer Ther; 2015 Jun; 14(6):1414-23. PubMed ID: 25833836
[TBL] [Abstract][Full Text] [Related]
19. High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy.
Lyu Q; Zhu W; Wei T; Ding W; Cao M; Wang Q; Guo L; Luo P; Zhang J
Cancer Med; 2021 Nov; 10(21):7863-7876. PubMed ID: 34564955
[TBL] [Abstract][Full Text] [Related]
20. Overcoming Chemotherapy Resistance in SCLC.
Herzog BH; Devarakonda S; Govindan R
J Thorac Oncol; 2021 Dec; 16(12):2002-2015. PubMed ID: 34358725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
